New York State Common Retirement Fund Pardes Biosciences, Inc. Transaction History

New York State Common Retirement Fund

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$1.4 - $1.95 $32,479 - $45,240	-23,200 Reduced 98.72%	300 $1,000
Q3 2022 Nov 08, 2022	BUY	$2.14 - $3.7 $642 - $1,110	300 Added 1.29%	23,500 $43,000
Q2 2022 Aug 04, 2022	BUY	$2.84 - $8.57 $65,888 - $198,824	23,200 New	23,200 $71,000

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.